Portage Biotech Inc.
PRTG
$5.53
-$0.50-8.29%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -47.96% | 11.97% | 5.48% | -43.62% | -18.92% |
| Depreciation & Amortization | -53.33% | -27.27% | -- | 1,400.00% | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -72.90% | -43.15% | -18.01% | -15.13% | 62.74% |
| Operating Income | 72.90% | 43.15% | 18.01% | 15.13% | -62.74% |
| Income Before Tax | 77.57% | 72.62% | 77.23% | -821.82% | -66.90% |
| Income Tax Expenses | -- | 101.38% | 100.01% | -531.88% | 64.47% |
| Earnings from Continuing Operations | 73.63% | 71.92% | 73.62% | -424.97% | -376.04% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -71.43% | 14.29% | 242.86% | -68.75% | -94.85% |
| Net Income | 73.63% | 72.02% | 73.65% | -426.03% | -443.52% |
| EBIT | 72.90% | 43.15% | 18.01% | 15.13% | -62.74% |
| EBITDA | 72.95% | 43.19% | 18.34% | 15.44% | -- |
| EPS Basic | 78.19% | 76.40% | 78.23% | -328.91% | -411.20% |
| Normalized Basic EPS | 81.10% | 71.88% | 148.35% | -12.42% | -60.28% |
| EPS Diluted | 78.21% | 76.38% | 78.23% | -328.21% | -383.33% |
| Normalized Diluted EPS | 81.10% | 71.88% | 148.35% | -12.42% | -60.28% |
| Average Basic Shares Outstanding | 20.90% | 18.53% | 21.02% | 22.64% | 6.32% |
| Average Diluted Shares Outstanding | 20.90% | 18.53% | 21.02% | 22.64% | 6.32% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
